Journal of Cancer Survivorship

Springer Science+Business Media

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Cancer Survivorship is a journal published by Springer Science+Business Media in United States. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,190 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Science+Business Media
ISSN
1932-2259 · 1932-2267
Country
United States
Access
Not open access / not declared
Declared publication charge
4,190 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2007-01-01
Indexing
MEDLINE
APC
4,190 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
88 days received→accepted — computed from PubMed (n=97)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

2032

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

108

i10-index

1166

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
97%
ORCID iDs in current deposits
22%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101307557
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Cancer survivorship and care
  • Cancer survivorship and care
  • Cancer survivorship and care
  • Childhood Cancer Survivors' Quality of Life
  • Cancer-related cognitive impairment studies
  • Cancer-related cognitive impairment studies
  • Childhood Cancer Survivors' Quality of Life
  • Childhood Cancer Survivors' Quality of Life
Show all subjects (75)
  • Global Cancer Incidence and Screening
  • Cancer-related cognitive impairment studies
  • Economic and Financial Impacts of Cancer
  • Economic and Financial Impacts of Cancer
  • Family Support in Illness
  • Family Support in Illness
  • Economic and Financial Impacts of Cancer
  • Women's cancer prevention and management
  • Cancer Risks and Factors
  • Cancer Risks and Factors
  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • Physical Activity and Health
  • Cancer Risks and Factors
  • Patient-Provider Communication in Healthcare
  • Physical Activity and Health
  • Physical Activity and Health
  • Palliative Care and End-of-Life Issues
  • Palliative Care and End-of-Life Issues
  • Mobile Health and mHealth Applications
  • Nutrition and Health in Aging
  • Nutrition and Health in Aging
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Lymphatic System and Diseases
  • Lymphatic System and Diseases
  • Multiple and Secondary Primary Cancers
  • Health Literacy and Information Accessibility
  • Frailty in Older Adults
  • Frailty in Older Adults
  • Medication Adherence and Compliance
  • Family Support in Illness
  • Medication Adherence and Compliance
  • Patient-Provider Communication in Healthcare
  • Patient-Provider Communication in Healthcare
  • Reproductive Biology and Fertility
  • Health Policy Implementation Science
  • Reproductive Biology and Fertility
  • Prostate Cancer Diagnosis and Treatment
  • Cancer Treatment and Pharmacology
  • Prostate Cancer Diagnosis and Treatment
  • Medical Practices and Rehabilitation
  • Cancer Treatment and Pharmacology
  • Reproductive Biology and Fertility
  • Advanced Breast Cancer Therapies
  • Oral health in cancer treatment
  • Advanced Breast Cancer Therapies
  • Oral health in cancer treatment
  • Head and Neck Cancer Studies
  • Frailty in Older Adults
  • Palliative and Oncologic Care
  • Acute Lymphoblastic Leukemia research
  • COVID-19 and healthcare impacts
  • COVID-19 and healthcare impacts
  • Brain Metastases and Treatment
  • Prostate Cancer Diagnosis and Treatment
  • Lymphatic System and Diseases
  • Adolescent and Pediatric Healthcare
  • Nursing care and research
  • Brain Metastases and Treatment
  • Adolescent and Pediatric Healthcare
  • Intensive Care Unit Cognitive Disorders
  • Digital Mental Health Interventions
  • Health Literacy and Information Accessibility
  • Health Literacy and Information Accessibility

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: